Idiopathic Pulmonary Fibrosis Clinical Trials in Ann Arbor, Michigan

3 studies are recruiting for idiopathic pulmonary fibrosis in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Idiopathic Pulmonary Fibrosis (IPF) is a rare, long-lasting lung disease that causes scarring of lung tissue, shortness of breath, and loss of lung function. IPF leads to significant loss of quality of life and shortened lifespan. This study is a platform study evaluating different types of treatme…

    Stage
    Phase 2
    Ages
    40 and older
    Site
    University of Michigan Health System - Ann Arbor /ID# 279994, Ann Arbor, Michigan
    Locations
    57 in total
    Run by
    AbbVie

    See if you can join NCT07230288 on ClinicalTrials.gov

  2. A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550. The goal of this study is to find out how well people with …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    373 in total
    Run by
    Boehringer Ingelheim

    See if you can join NCT06238622 on ClinicalTrials.gov

  3. WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

    Stage
    Phase 2
    Ages
    40 and older
    Site
    WISPer Site in Ann Arbor, MI, Ann Arbor, Michigan
    Locations
    71 in total
    Run by
    Mediar Therapeutics

    See if you can join NCT06967805 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.